Scientific Publications


Natural history and real-world treatment outcomes for non-small cell lung cancer patients with EGFR exon 20 insertion mutation: An IASLC- ASCO CancerL…

JTO Clin Res Rep
Behera M et al

Real-world pitfalls of analyzing real-world data: A cautionary note and path forward

JCO Clinical Cancer Informatics
Cooper J et al

Prognostic impact of second primary malignancies in multiple myeloma: An ASCO CancerLinQ Discovery analysis of the modern era [CORRESPONDENCE]

American Journal of Hematology
Gibson S et al

Multiple myeloma in adolescent and young adults: An ASCO CancerLinQ and SEER analysis

Clinical Lymphoma, Myeloma and Leukemia
Gibson S et al

Health data sharing perspectives of patients receiving care in CancerLinQ-participating oncology practices

JCO Oncology Practice
Jagsi R et al

Real-world big-data: Strengths and weaknesses of ASCO's CancerLinQ Discovery® multiple myeloma dataset

American Journal of Hematology
DeStefano CB

Evaluation of cost-effectiveness of adjuvant osimertinib in patients with resected EGFR mutation-positive non-small cell lung cancer

PharmacoEconomics - Open
Verhoek A et al

Challenges to using big data in cancer

Cancer Research
Sweeney SM et al

Case studies for overcoming challenges in using big data in cancer

Cancer Research
Sweeney SM et al


Disparities in genetic testing patterns and positivity among patients with breast cancer in the CancerLINQ real-world oncology database [Poster PO4-08…

2023 San Antonio Breast Cancer Symposium
Kantor O

Implementing a BRAF biomarker electronic clinical quality measure in CancerLinQ

2023 ASCO Quality Care Symposium
Drumheller C

Uptake and efficacy of immuno-oncology combinations in metastatic renal cell carcinoma in the United States: Evidence from the ASCO CancerLinQ Discove…

2023 ASCO Quality Care Symposium
Vento J

Pitfalls with analyses of real-world data: A look at ASCO’s CancerLinQ Discovery Multiple Myeloma dataset

ASCO Annual Meeting 2023
Shou K J et al

A real-world study of US patients with metastatic ovarian, fallopian tube, and peritoneal cancer (mOFPC) using integrated electronic health records (E…

ASCO Annual Meeting 2023
Avinash P B et al

The RESECT study: Factors associated with overall survival (OS) and relapse-free survival (RFS) among patients with stages I–III resected NSCLC withou…

ASCO Annual Meeting 2023
Gray J E et al

Real-world response endpoints in patients with mNSCLC treated with chemotherapy across real-world datasets

ASCO Annual Meeting 2023
McKelvey B A et al

Electronic health record (EHR) and genomics-based machine learning (ML) to predict therapeutic effectiveness among patients with hormone-receptor posi…

ASCO Annual Meeting 2023
Hathi D et al

Association between severe adverse event management and overall survival in patients treated with immune checkpoint inhibitor with advanced non–small-…

ASCO Annual Meeting 2023
Naidoo J et al